23 May 2013
Keywords: Leo Pharma, Peplin, Mergers & acquisitions, dermatology
Article | 03 September 2009
Denmark-based Leo Pharma will acquire all outstanding securities of Peplin, a US firm with operations in Australia, for around $287.5 million ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2009
22 May 2013
© 2013 thepharmaletter.com